Clinical Trial Update: Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the immunogenicity and safety of a combined meningococcal A/C and Haemophilus influenzae type b conjugate vaccine in infan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection
• Meningitis
• Meningococcal Disease

Drugs mentioned

• Meningococcal A/C + Hib conjugate vaccine (Meningococcal A/C and Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Meningitis, Meningococcal Meningitis | Phase 1, Phase 2 | Status: UNKNOWN